Evaluation of a 99Mtc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin Αvβ3-Positive Breast Cancer

Shuang Liu,Wen-Yuan Hsieh,Young Jiang,Young-Seung Kim,Subramanya G. Sreerama,Xiaoyuan Chen,Bing Jia,Fan Wang
DOI: https://doi.org/10.1021/bc0603081
IF: 4.7
2007-01-01
Bioconjugate Chemistry
Abstract:Integrin alpha(v)beta(3) plays a critical role in tumor angiogenesis and metastasis. Radiolabeled RGD peptides that are integrin alpha(v)beta(3)-specific are very useful for noninvasive imaging of integrin expression in rapidly growing and metastatic tumors. In this study, we determined the binding affinity of E{E[c(RGDfK)](2)}(2) (tetramer) and its 6-hydrazinonicotinamide conjugate (HYNIC-tetramer) against the binding of I-125-echistatin to the integrin alpha(v)beta(3)-positive MDA-MB-435 breast cancer cells. The athymic nude mice bearing MDA-MB-435 xenografts were used to evaluate the potential of ternary ligand complex [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] (TPPTS = trisodium triphenylphosphine-3,3',3' '-trisulfonate) as a new radiotracer for imaging breast cancer integrin alpha(v)beta(3) expression by single photon emission computed tomography (SPECT). It was found that the binding affinity of tetramer (IC50 = 51 +/- 11 nM) was slightly higher than that of its dimeric analogue (IC50 = 78 +/- 27 nM) and is comparable to that of the HYNIC-tetramer conjugate (IC50 = 55 +/- 11 nM) within the experimental error. Biodistribution data showed that [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] had a rapid blood clearance (4.61 +/- 0.81 %ID/g at 5 min postinjection (p.i.) and 0.56 +/- 0.12 %ID/g at 120 min p.i.) and was excreted mainly via the renal route. [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] had high tumor uptake with a long tumor retention (5.60 +/- 0.87 %ID/g and 7.30 +/- 1.32 %ID/g at 5 and 120 min p.i., respectively). The integrin alpha(v)beta(3)-specificity was demonstrated by co-injection of excess E[c(RGDfK)](2), which resulted in a significant reduction in tumor uptake of the radiotracer. The metabolic stability of [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] was determined by analyzing urine and feces samples from the tumor-bearing mice at 120 min p.i. In the urine, about 20% of [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] remained intact while only similar to 15% metabolized species was detected in feces. SPECT images displayed significant radiotracer localization in tumor with good contrast as early as 1 h p.i. The high tumor uptake and fast renal excretion make [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] a promising radiotracer for noninvasive imaging of the integrin alpha(v)beta(3)-positive tumors by SPECT.
What problem does this paper attempt to address?